CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
2.840
-0.120 (-4.05%)
At close: Mar 12, 2026, 4:00 PM EDT
2.820
-0.020 (-0.70%)
After-hours: Mar 12, 2026, 7:41 PM EDT
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $1.76 million as of March 12, 2026. Its market cap has decreased by -51.65% in one year.
Market Cap
1.76M
Enterprise Value
-8.02M
1-Year Change
-51.65%
Ranking
Category
Stock Price
$2.84
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $1.76M, a decrease of -97.48%. That is a compound annual growth rate of -44.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 1.76M | -45.90% |
| Dec 31, 2025 | 3.26M | -52.95% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enveric Biosciences | 2.77M |
| Propanc Biopharma | 2.73M |
| Scinai Immunotherapeutics | 2.57M |
| 60 Degrees Pharmaceuticals | 2.48M |
| Adial Pharmaceuticals | 2.46M |
| Lyra Therapeutics | 2.31M |
| Jaguar Health | 2.23M |
| Bone Biologics | 2.19M |